Clinical Trial

Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 17, 2024 (before its estimated August 18, 2024 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to determine if Qualia NAD+ effectively increases NAD+ levels in the blood and to evaluate its safety. Researchers will compare Qualia NAD+ to a placebo (a look-alike substance that contains no active drug) to assess its efficacy in increasing NAD+ levels in the blood. Participants will: Take Qualia NAD+ or a placebo every day for 4 weeks. Undergo blood tests before and after the trial.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06505967
Lead Sponsor Qualia Life Sciences
Conditions NAD+ Levels in the Blood
Enrollment 200 participants
Start Date 2024-06-10
Primary Completion 2024-08-18 (estimated)
Study Completion 2024-09-09 (estimated)
Updated on ClinicalTrials.gov 2024-07-17